Helicobacter pylori: Bacteriology and laboratory diagnosis

Journal of Infection

Volumn 34, Issue 1, 1997, Pages 1-5

  Williams, C L ^a  

^a ROYAL ALEXANDRA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIOLOGY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; LABORATORY DIAGNOSIS; SHORT SURVEY;

EID: 0031046537     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-4453(97)80002-3     Document Type: Article

References (57)

1. Marshall BJ, Royce H, Annear DI et al. Original isolation of Campylobacter pyloris from human gastric mucosa. Microbios Lett 1984; 25: 83-88.
2. Hentshcel E, Brandsatter G, Dragosics B. Effect of ranitidine and amoxycillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993; 328: 308-312.
3. Nomura A, Stemmermann GN, Chyou P, Kato I, Perez-Perez GI, Blaser MJ. H. pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991; 325: 1132-1136.
4. Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; i: 1273-1275.
5. Lee A. The microbiology and epidemiology of H. pylori infection. Scand J Gastroenterol Suppl 201: 2-6.
6. Stark RM, Greenman J, Millar MR. Physiology and Biochemistry of H. pylori. Br J Biomed Sci 1995; 52: 282-290.
7. Moran AP. Cell surface characteristics of Helicobacter pylori. FEMS Immunol Med Microbiol 1995; 10: 271-280.
8. Collins CM, D'Orazio SEF. Bacterial ureases: structure, regulation of expression and role in pathogenesis. Mol Microbiol 1993; 9: 907-913.
9. Suerbaum S, Josenhans C, Labigne A. Cloning and genetic characterisation of the Helicobacter pylori and Helicobacter mustelae flaB flaggelin genes and construction of H. pylori flaA and flaB negative mutants by electroporation-mediated allelic exchange. J Bacteriol 1993; 175: 3278-3288.
10. Mendz GL, Hazell SL, VanGorkom L. Pyruvate metabolism in H. pylori. Arch Microbiol 1994; 162: 187-192.
11. Mendz GL, Jiminez BM, Hazell SL, Gero AM, O'Sullivan WJ. Salvage synthesis of pyrimidine nucleotides by H. pylori. J App Bacteriol 1994; 77: 674-681.
12. Mobley HLT, Cortesia MJ, Rosenthal LE, Jones BD. Characterisation of urease from C. pylori. J Clin Microbiol 26: 831-836.
13. Marshall BJ, Barrett LJ, Prakash C, McCallum RW, Guerrant RL. Urea protects Helicobacter (Campylobacter) pylori from the bacteriocidal effect of acid. Gastroenterology 1990; 99: 679-702.
14. Greig M, Neithercutt WD, Hossack K, McColl KEL. Harnessing of urease activity of Helicobacter pylori to induce self destruction of the bacteria. J Clin Pathol 1991; 44: 157-159.
15. Neithercutt WD, Williams C, Hossack M, McColl KEL. Ammonium metabolism and protection from urease mediated destruction in H. pylori infection. J Clin Pathol 1993; 46: 75-78.
16. Williams CL, Preston T, Hossack M, Slater C, McColl KEL. Helicobacter pylori utilises urea for amino acid synthesis. FEMS Immunol Med Microbiol 1996; 13: 87-94.
17. Akopyanz N, Bukanov NO, Westblom TU, Kresovich S, Berg DE. DNA diversity among clinical isolates of H. pylori detected by PCR based RAPD fingerprinting. Nucleic Acids Res 1992; 20: 5137-5142.
18. Fujimoto S, Marshall B, Blaser MJ. PCR based restriction fragment length polymorphism typing of H. pylori. J Clin Microbiol 1994; 32: 331-334.
19. Prewett EJ, Bickley J, Owen RJ, Pounder RE. DNA patterns of H. pylori isolated from gastric antrum, body and duodenum. Gastroenterology 1992; 102: 829-833.
20. Blaser MJ. Intrastrain differences in H. pylori: a key question in mucosal damage. Ann Med 1995; 27: 559-563.
21. Shuto R, Fujioka T, Kubota T, Nasu M. Experimental gastritis induced by H. pylori in Japanese monkeys. Infect Immun 1993; 61: 933-939.
22. Karita M, Kouchiyama T, Okita K, Nakazawa T. New small animal model for human gastric H. pylori infection: success in both nude and athymic mice. Am J Gastroenterol 1991; 86: 1596-602.
23. Lambert JR, Borromeo M, Pinkard KJ, Turner H, Chapman CB. Colonisation of gnotobiotic piglets with C. pyloridis - an animal model? J Infect Dis 987; 155: 1344-1346.
24. Solnick JV, O'Rourke J, Lee A, Tompkins LS. Molecular analysis of urease genes from a newly identified uncultured species of Helicobacter. Infect Immun 1994; 62: 1631-1638.
25. Lee A, O'Rourke J. Gastric bacteria other than H. pylori. Gastroenterol Clin N Am 1993; 22: 21-42.
26. Dewhirst FE, Seymour C, Fraser GJ, Paster BJ, Fox JG. Phylogeny of Helicobacter isolates from bird and swine faeces and description of Helocobacter pametensis sp. nov. Int J Syst Bact 1994; 44: 553-560.
27. Lee A. Peptic ulceration in H. pylori induced ulcerogensis - look to the host. Lancet 1993; 341: 280-281.
28. Leunk RD. Production of a cytotoxin by H. pylori. Rev Infect Dis 1991; 13: 5686-5689.
29. Cover TL, Blaser MJ. Purification and characterisation of the vacuolating cytotoxin from H. pylori. J Biol Chem 1992; 267: 10570-10575.
30. Papini E, Bugnoli M, DeBenard M, Figura M, Rapouli R, Montecucco C. Bafilomycin-A1 inhibits H. pylori induced vacuolation of HeLa cells. Molec Microbiol 1993; 7: 323-327.
31. Telford JL, Ghiora P, Dell'Orca M. Gene structure of H. pylori and evidence of its key role in gastric disease. J Exp Med 1994; 179: 1653-1658.
32. Cover TL, Tummuru MKR, Cao P, Thompson SA, Blaser MJ. Divergence of genetic sequences for the vacuolating cytotoxin among H. pylori strains. J Biol Chem 1994; 269: 10566-10573.
33. Covacci A, Censini S, Bugnoli M, Petracca R, Burroni D, Macchia G. Molecular characterisation of the 128 kDa immunodominant antigen of H. pylori associated with cytotoxicity and duodenal ulceration. Proc Natl Acad Sci USA 1993; 90: 5971-5975.
34. Cover TL, Dooley CP, Blaser MJ. Characterisation and human serologic response to proteins in H. pylori broth culture supernatants with vacuolating cytotoxin activity. Infect Immun 1990; 58: 603-610.
35. Crabtree JE, Farmery SM, Lindlay IJD, Figura N, Peichl P, Tompkins DS. CagA/cytotoxic strains of H. pylori and Interleukin 8 in gastric epithelial cell lines. J Clin Pathol 1994; 47: 945-950.
36. Crabtree JE, Taylor JD, Wyatt JI, Heatley RV, Shallcross TM, Tompkins DS. Mucosal IgA recognition of H. pylori 120 kDa protein, peptic ulceration and gastric pathology. Lancet 1991; 338: 332-335.
37. + H. pylori strains. J Clin Microbiol 1995; 33: 1496-1500.
38. Tummuru MKR, Cover TL, Blaser MJ. Mutation of the cytotoxin associated CagA gene does not affect the vacuolating cytotoxin activity of H. pylori. Infect Immun 1994; 62: 2609-2613.
39. Goodwin CS, Blincow ED, Warren JR, Waters TE, Sanderson CR, Easton L. Evaluation of cultural techniques for isolating Campylobacter pyloridis from endoscopic biopsies of gastric mucosa. J Clin Pathol 1985; 38: 1127-1131.
40. Xia H, Keane CT, Beattie S, O'Morain CA. Standardisation of disk diffusion test and its clinical significance for susceptible testing of metronidazole against H. pylori. Antimicrob Agents Chemother 1994 38: 2357-2361.
41. Glupczynski Y, Labbe M, Hansen W, Crokaert F, Yourassowsky E. Evaluation of the E test for quantitative antimicrobial susceptibility testing of H. pylori. J Clin Microb 1991; 29: 2072-2075.
42. Karim QN, Logan RPH. The epidemiology of H. pylori antimicrobial resistance - preliminary findings of a national survey. Gut 1995; 37 (Suppl. 2): A6.
43. Cayla R, Zerbib F, Talbi P, Megreaud F, Lamouliatte H. Pre and post treatment clarithromycin resistance of H. pylori strains: a key factor in treatment failure. Gut 1995; 37 (Suppl. 1): A55.
44. Moayyedi P, Sahay P, Tompkins DS, Axon ATR. Efficacy and optimum dose of omeprazole in a new 1 week triple therapy regimen to eradicate H. pylori. Eur J Gastroenterol Hepato 1995; 7: 835-840.
45. Goddard AF, Logan RPH. Antimicrobial resistance and H. pylori. J Antimicrob Chemother 1996; 37: 639-643.
46. Rathbone BJ, Wyatt JI, Worsley BW. Systemic and local antibody responses to gastric Campylobacter pyloridis in non ulcer dyspepsia. Gut 1986; 27: 642-647.
47. Steer HW, Hawtin PR, Newell DG An ELISA technique for the serodiagnosis of C. pyloridis infection in patients with gastritis and benign duodenal ulceration. Serodiagnosis Immunother 1987; 1: 253-259.
48. Morris A, Nicholson G. Ingestion of C. pyloridis causes gastritis and raised fgasting pH. Am J Gastroenterol 1987; 82: 192-199.
49. Rathbone BJ, Wyatt JI, Worsley BW. Immune response to C. pyloridis. Lancet 1985; ii: 1217.
50. Stacy AR, Hawtin PR, Newell DG. Antigenicity of fractions of H. pylori prepared by FPLC and urease capture by monoclonal antibodies. Eur J Clin Microbiol Infect Dis 1990; 9: 732-737.
51. Evans DJ, Evans DG, Smith KE. Serum antibody response to the N-acetylneuramyllactose binding haemagglutinin of C. pylori. Infect Immun 1989; 57: 664-667.
52. Kosunen TU, Seppala K, Sarna S, Sipponen P. Diagnostic value of decreasing IgG, AgA & IgM antibody titres after eradication of H. pylori. Lancet; 339: 893-895.
53. Luzza F, Malletta M, Imeneo M. Salivary specific IgG is a sensitive indication of the humoral response to H. pylori. FEMS Immunol Med Microbiol 10: 281-284.
54. Weiss J, Mecca J, DaSilva E. Comparison of PCR and other diagnostic techniques for detection of H. pylori in dyspeptic patients. J Clin Microb 1994; 32: 1663-1668.
55. Li C, Musich PR, Ha T. High prevalence of H. pylori in saliva demonstrated by a novel PCR assay. J Clin Pathol 1995; 48: 662-666.
56. Mapstone NP, Lewis FA, Tompkins DS. PCR identification of H. pylori in faeces from gastritis patients. Lancet 1993; 341: 447.
57. Enroth H, Engstrand L. Immunomagnetic separation and PCR for detection of H. pylori in water and stool specimens. J Clin Microbiol 1995; 33: 2162-2165.